Leading the Way in Life Science Technologies

GEN Exclusives

More »
Insight & Intelligence™

Related to Amplimmune Gets $23M Up Front from GSK to Develop PD-1-Targeting Drugs

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »